Advertisement
Screener

NEPHROS, INC. (NEPH) Long-Term Debt, Maturity, Year Four

2.8 / 5 stars · 68/120 Roast Me

NEPHROS, INC. Long-Term Debt, Maturity, Year Four

NEPHROS, INC. (NEPH) had Long-Term Debt, Maturity, Year Four of $95.00 thousand as of 2020-03-31, per its 10-Q filed 2020-05-06.

Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2020-05-06

  • 2020-03-31: Long-Term Debt, Maturity, Year Four $95.00K.
  • 2019-12-31: Long-Term Debt, Maturity, Year Four $95.00K.
  • 2019-09-30: Long-Term Debt, Maturity, Year Four $271.00K.
  • 2019-06-30: Long-Term Debt, Maturity, Year Four $71.00K.
Period endLong-Term Debt, Maturity, Year Four
2020-03-31$95.00K
10-Q · filed 2020-05-06
2019-12-31$95.00K
10-K · filed 2020-02-27
2019-09-30$271.00K
10-Q · filed 2019-11-06
2019-06-30$71.00K
10-Q · filed 2019-08-07
2019-03-31$71.00K
10-Q · filed 2019-05-08
2018-12-31$269.00K
10-K · filed 2019-03-12
2018-09-30$271.00K
10-Q · filed 2018-11-08
2018-06-30$271.00K
10-Q · filed 2018-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
Spectral AI, Inc. (MDAI)United States$0.052B
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
TELA Bio, Inc. (TELA)United States$0.057B-0.82
InspireMD, Inc. (NSPR)$0.033B
PAVmed Inc. (PAVM)United States$0.031B-3.00
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
DarioHealth Corp. (DRIO)$0.066B-1.39